EMERGENT BIOSOLUTIONS INC. Research and Development Expense
EMERGENT BIOSOLUTIONS INC. (EBS) reported Research and Development Expense of $9.20 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-06
- EMERGENT BIOSOLUTIONS INC. research and development expense for the quarter ending 2026-06-30 was $9.20M, a 26.40% decline year-over-year.
- EMERGENT BIOSOLUTIONS INC. research and development expense for the quarter ending 2026-03-31 was $10.50M, a 30.46% decline year-over-year.
- EMERGENT BIOSOLUTIONS INC. research and development expense for the quarter ending 2025-12-31 was $12.10M, a 32.97% increase year-over-year.
- EMERGENT BIOSOLUTIONS INC. research and development expense for the quarter ending 2025-09-30 was $13.50M, a 2.17% decline year-over-year.
- EMERGENT BIOSOLUTIONS INC. research and development expense for fiscal 2025 was $53.20M, a 24.75% decline from fiscal 2024.
- EMERGENT BIOSOLUTIONS INC. research and development expense for fiscal 2024 was $70.70M, a 36.54% decline from fiscal 2023.
- EMERGENT BIOSOLUTIONS INC. research and development expense for fiscal 2023 was $111.40M, a 40.84% decline from fiscal 2022.
- EMERGENT BIOSOLUTIONS INC. research and development expense for fiscal 2022 was $188.30M, a 19.94% decline from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $9.20M 10-Q · filed 2026-08-06 | $19.70M 10-Q · filed 2026-08-06 | $31.80M derived: sum of 3 quarters · filed 2026-08-06 | $45.30M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $10.50M 10-Q · filed 2026-05-01 | $22.60M derived: sum of 2 quarters · filed 2026-05-01 | $36.10M derived: sum of 3 quarters · filed 2026-05-01 | $48.60M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $12.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $25.60M derived: sum of 2 quarters · filed 2026-02-27 | $38.10M derived: sum of 3 quarters · filed 2026-08-06 | $53.20M 10-K · filed 2026-02-27 | ||||
| 2025-09-30 | $13.50M 10-Q · filed 2025-10-30 | $26.00M derived: sum of 2 quarters · filed 2026-08-06 | $41.10M 10-Q · filed 2025-10-30 | $50.20M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $12.50M 10-Q · filed 2026-08-06 | $27.60M 10-Q · filed 2026-08-06 | $36.70M derived: sum of 3 quarters · filed 2026-08-06 | $50.50M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $15.10M 10-Q · filed 2026-05-01 | $24.20M derived: sum of 2 quarters · filed 2026-05-01 | $38.00M derived: sum of 3 quarters · filed 2026-05-01 | $70.70M derived: sum of 4 quarters · filed 2026-05-01 | ||||
| 2024-12-31 | $9.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $22.90M derived: sum of 2 quarters · filed 2026-02-27 | $55.60M derived: sum of 3 quarters · filed 2026-02-27 | $70.70M 10-K · filed 2026-02-27 | ||||
| 2024-09-30 | $13.80M 10-Q · filed 2025-10-30 | $46.50M derived: sum of 2 quarters · filed 2025-10-30 | $61.60M 10-Q · filed 2025-10-30 | $91.00M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-06-30 | $32.70M 10-Q · filed 2025-08-07 | $47.80M 10-Q · filed 2025-08-07 | $77.20M derived: sum of 3 quarters · filed 2026-02-27 | $92.50M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-03-31 | $15.10M 10-Q · filed 2025-05-08 | $44.50M derived: sum of 2 quarters · filed 2026-02-27 | $59.80M derived: sum of 3 quarters · filed 2026-02-27 | $85.80M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2023-12-31 | $29.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $44.70M derived: sum of 2 quarters · filed 2026-02-27 | $70.70M derived: sum of 3 quarters · filed 2026-02-27 | $111.40M 10-K · filed 2026-02-27 | ||||
| 2023-09-30 | $15.30M 10-Q · filed 2024-11-07 | $41.30M derived: sum of 2 quarters · filed 2024-11-07 | $82.00M 10-Q · filed 2024-11-07 | $129.00M derived: sum of 4 quarters · filed 2025-03-04 | ||||
| 2023-06-30 | $26.00M 10-Q · filed 2024-08-07 | $66.70M 10-Q · filed 2024-08-07 | $66.60M 10-Q · filed 2023-08-09 | $113.70M derived: sum of 3 quarters · filed 2025-03-04 | $155.90M derived: sum of 4 quarters · filed 2025-03-04 | |||
| 2023-03-31 | $40.70M 10-Q · filed 2024-05-02 | $40.60M 10-Q · filed 2023-05-10 | $87.70M derived: sum of 2 quarters · filed 2025-03-04 | $129.90M derived: sum of 3 quarters · filed 2025-03-04 | $179.70M derived: sum of 4 quarters · filed 2025-03-04 | |||
| 2022-12-31 | $47.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $89.20M derived: sum of 2 quarters · filed 2025-03-04 | $139.00M derived: sum of 3 quarters · filed 2025-03-04 | $188.30M 10-K · filed 2025-03-04 | $193.00M 10-K · filed 2023-03-01 | |||
| 2022-09-30 | $42.20M 10-Q · filed 2023-12-11 | $39.20M 10-Q · filed 2022-11-09 | $92.00M derived: sum of 2 quarters · filed 2023-12-11 | $141.30M 10-Q · filed 2023-12-11 | $135.40M 10-Q · filed 2022-11-09 | $222.60M derived: sum of 4 quarters · filed 2024-03-08 | ||
| 2022-06-30 | $49.80M 10-Q · filed 2023-08-09 | $96.20M 10-Q · filed 2023-08-09 | $180.40M derived: sum of 3 quarters · filed 2024-03-08 | $230.00M derived: sum of 4 quarters · filed 2024-03-08 | ||||
| 2022-03-31 | $46.40M 10-Q · filed 2023-05-10 | $130.60M derived: sum of 2 quarters · filed 2024-03-08 | $180.20M derived: sum of 3 quarters · filed 2024-03-08 | $229.10M derived: sum of 4 quarters · filed 2024-03-08 | ||||
| 2021-12-31 | $84.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $133.80M derived: sum of 2 quarters · filed 2024-03-08 | $182.70M derived: sum of 3 quarters · filed 2024-03-08 | $235.20M 10-K · filed 2024-03-08 | $234.00M 10-K · filed 2022-02-25 | |||
| 2021-09-30 | $49.60M 10-Q · filed 2022-11-09 | $98.50M derived: sum of 2 quarters · filed 2022-11-09 | $151.00M 10-Q · filed 2022-11-09 | $213.90M derived: sum of 4 quarters · filed 2023-12-11 | ||||
| 2021-06-30 | $48.90M 10-Q · filed 2022-08-02 | $101.40M 10-Q · filed 2022-08-02 | $164.30M derived: sum of 3 quarters · filed 2023-12-11 | $248.70M derived: sum of 4 quarters · filed 2023-12-11 | ||||
| 2021-03-31 | $52.50M 10-Q · filed 2022-04-29 | $115.40M derived: sum of 2 quarters · filed 2023-12-11 | $199.80M derived: sum of 3 quarters · filed 2023-12-11 | $247.70M derived: sum of 4 quarters · filed 2023-12-11 | ||||
| 2020-12-31 | $62.90M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-12-11 | $147.30M derived: sum of 2 quarters · filed 2023-12-11 | $195.20M derived: sum of 3 quarters · filed 2023-12-11 | $237.90M 10-K/A · filed 2023-12-11 | $234.50M 10-K · filed 2021-02-19 | |||
| 2020-09-30 | $84.40M 10-Q · filed 2021-11-05 | $132.30M derived: sum of 2 quarters · filed 2021-11-05 | $175.00M 10-Q · filed 2021-11-05 | $237.80M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-06-30 | $47.90M 10-Q · filed 2021-07-30 | $90.60M 10-Q · filed 2021-07-30 | $153.40M derived: sum of 3 quarters · filed 2022-02-25 | $206.80M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-03-31 | $42.70M 10-Q · filed 2021-04-30 | $105.50M derived: sum of 2 quarters · filed 2022-02-25 | $158.90M derived: sum of 3 quarters · filed 2022-02-25 | $222.80M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2019-12-31 | $62.80M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $116.20M derived: sum of 2 quarters · filed 2022-02-25 | $180.10M derived: sum of 3 quarters · filed 2022-02-25 | $226.20M 10-K · filed 2022-02-25 | ||||
| 2019-09-30 | $53.40M 10-Q · filed 2020-11-06 | $117.30M derived: sum of 2 quarters · filed 2020-11-06 | $163.40M 10-Q · filed 2020-11-06 | $215.40M derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2019-06-30 | $63.90M 10-Q · filed 2020-07-31 | $110.00M 10-Q · filed 2020-07-31 | $162.00M derived: sum of 3 quarters · filed 2021-02-19 | $199.00M derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2019-03-31 | $46.10M 10-Q · filed 2020-05-01 | $98.10M derived: sum of 2 quarters · filed 2021-02-19 | $135.10M derived: sum of 3 quarters · filed 2021-02-19 | $159.80M derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2018-12-31 | $52.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $89.00M derived: sum of 2 quarters · filed 2021-02-19 | $113.70M derived: sum of 3 quarters · filed 2021-02-19 | $142.80M 10-K · filed 2021-02-19 | ||||
| 2018-09-30 | $37.00M 10-Q · filed 2019-11-07 | $37.01M 10-Q · filed 2018-11-02 | $61.70M derived: sum of 2 quarters · filed 2019-11-07 | $90.80M 10-Q · filed 2019-11-07 | $90.80M 10-Q · filed 2018-11-02 | $119.31M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2018-06-30 | $24.70M 10-Q · filed 2019-08-02 | $24.75M 10-Q · filed 2018-08-03 | $53.80M 10-Q · filed 2019-08-02 | $53.80M 10-Q · filed 2018-08-03 | $82.31M derived: sum of 3 quarters · filed 2020-02-25 | $104.97M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2018-03-31 | $29.10M 10-Q · filed 2019-05-08 | $29.05M 10-Q · filed 2018-05-04 | $57.61M derived: sum of 2 quarters · filed 2020-02-25 | $80.27M derived: sum of 3 quarters · filed 2020-02-25 | $106.02M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2017-12-31 | $28.51M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $51.17M derived: sum of 2 quarters · filed 2020-02-25 | $76.92M derived: sum of 3 quarters · filed 2020-02-25 | $97.40M 10-K · filed 2020-02-25 | $97.38M 10-K · filed 2018-02-23 | |||
| 2017-09-30 | $22.66M 10-Q · filed 2018-11-02 | $48.41M derived: sum of 2 quarters · filed 2018-11-02 | $68.89M 10-Q · filed 2018-11-02 | $94.61M derived: sum of 4 quarters · filed 2019-02-22 | ||||
| 2017-06-30 | $25.75M 10-Q · filed 2018-08-03 | $46.23M 10-Q · filed 2018-08-03 | $71.95M derived: sum of 3 quarters · filed 2019-02-22 | $99.14M derived: sum of 4 quarters · filed 2019-02-22 | ||||
| 2017-03-31 | $20.48M 10-Q · filed 2018-05-04 | $46.20M derived: sum of 2 quarters · filed 2019-02-22 | $73.39M derived: sum of 3 quarters · filed 2019-02-22 | $101.28M derived: sum of 4 quarters · filed 2019-02-22 | ||||
| 2016-12-31 | $25.73M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $52.91M derived: sum of 2 quarters · filed 2019-02-22 | $80.81M derived: sum of 3 quarters · filed 2019-02-22 | $106.90M 10-K · filed 2019-02-22 | $108.29M 10-K · filed 2017-02-28 | |||
| 2016-09-30 | $27.19M 10-Q · filed 2017-11-03 | $55.08M derived: sum of 2 quarters · filed 2017-11-03 | $81.17M 10-Q · filed 2017-11-03 | $106.53M derived: sum of 4 quarters · filed 2018-02-23 | ||||
| 2016-06-30 | $27.89M 10-Q · filed 2017-08-04 | $35.35M 10-Q · filed 2016-08-05 | $53.98M 10-Q · filed 2017-08-04 | $69.50M 10-Q · filed 2016-08-05 | $79.34M derived: sum of 3 quarters · filed 2018-02-23 | $113.52M derived: sum of 4 quarters · filed 2018-02-23 | ||
| 2016-03-31 | $26.09M 10-Q · filed 2017-05-05 | $34.15M 10-Q · filed 2016-05-06 | $51.45M derived: sum of 2 quarters · filed 2018-02-23 | $85.63M derived: sum of 3 quarters · filed 2018-02-23 | $126.57M derived: sum of 4 quarters · filed 2018-02-23 | |||
| 2015-12-31 | $25.35M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $59.53M derived: sum of 2 quarters · filed 2018-02-23 | $100.47M derived: sum of 3 quarters · filed 2018-02-23 | $119.19M 10-K · filed 2018-02-23 | $154.00M 10-K · filed 2016-02-29 | |||
| 2015-09-30 | $34.18M 10-Q · filed 2016-11-09 | $41.87M 10-Q · filed 2015-11-06 | $75.12M derived: sum of 2 quarters · filed 2016-11-09 | $93.83M 10-Q · filed 2016-11-09 | $121.51M 10-Q · filed 2015-11-06 | $106.68M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2015-06-30 | $40.94M 10-Q · filed 2016-08-05 | $79.64M 10-Q · filed 2016-08-05 | $72.50M derived: sum of 3 quarters · filed 2017-02-28 | $116.71M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | $38.70M 10-Q · filed 2016-05-06 | $31.56M derived: sum of 2 quarters · filed 2017-02-28 | $75.77M derived: sum of 3 quarters · filed 2017-02-28 | $113.17M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-31 | -$7.14M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $37.06M derived: sum of 2 quarters · filed 2017-02-28 | $74.47M derived: sum of 3 quarters · filed 2017-02-28 | $104.72M 10-K · filed 2017-02-28 | $150.83M 10-K · filed 2015-03-09 | |||
| 2014-09-30 | $44.21M 10-Q · filed 2015-11-06 | $81.61M derived: sum of 2 quarters · filed 2015-11-06 | $111.86M 10-Q · filed 2015-11-06 | $141.86M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | $37.40M 10-Q · filed 2015-08-06 | $67.66M 10-Q · filed 2015-08-06 | $97.65M derived: sum of 3 quarters · filed 2016-02-29 | $126.59M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | $30.26M 10-Q · filed 2015-05-08 | $60.25M derived: sum of 2 quarters · filed 2016-02-29 | $89.19M derived: sum of 3 quarters · filed 2016-02-29 | $119.47M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $29.99M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $58.93M derived: sum of 2 quarters · filed 2016-02-29 | $89.21M derived: sum of 3 quarters · filed 2016-02-29 | $119.93M 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | $28.94M 10-Q · filed 2014-11-10 | $59.22M derived: sum of 2 quarters · filed 2014-11-10 | $89.94M 10-Q · filed 2014-11-10 | $125.88M derived: sum of 4 quarters · filed 2015-03-09 | ||||
| 2013-06-30 | $30.28M 10-Q · filed 2014-08-08 | $61.00M 10-Q · filed 2014-08-08 | $96.95M derived: sum of 3 quarters · filed 2015-03-09 | $124.34M derived: sum of 4 quarters · filed 2015-03-09 | ||||
| 2013-03-31 | $30.72M 10-Q · filed 2014-05-12 | $66.67M derived: sum of 2 quarters · filed 2015-03-09 | $94.06M derived: sum of 3 quarters · filed 2015-03-09 | $124.70M derived: sum of 4 quarters · filed 2015-03-09 | ||||
| 2012-12-31 | $35.95M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $63.34M derived: sum of 2 quarters · filed 2015-03-09 | $93.98M derived: sum of 3 quarters · filed 2015-03-09 | $120.23M 10-K · filed 2015-03-09 | ||||
| 2012-09-30 | $27.39M 10-Q · filed 2013-11-08 | $58.03M derived: sum of 2 quarters · filed 2013-11-08 | $84.28M 10-Q · filed 2013-11-08 | $113.66M derived: sum of 4 quarters · filed 2014-03-10 | ||||
| 2012-06-30 | $30.64M 10-Q · filed 2013-08-06 | $56.89M 10-Q · filed 2013-08-06 | $86.27M derived: sum of 3 quarters · filed 2014-03-10 | $115.48M derived: sum of 4 quarters · filed 2014-03-10 | ||||
| 2012-03-31 | $26.25M 10-Q · filed 2013-05-03 | $55.62M derived: sum of 2 quarters · filed 2014-03-10 | $84.84M derived: sum of 3 quarters · filed 2014-03-10 | $116.32M derived: sum of 4 quarters · filed 2014-03-10 | ||||
| 2011-12-31 | $29.38M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-10 | $58.59M derived: sum of 2 quarters · filed 2014-03-10 | $90.07M derived: sum of 3 quarters · filed 2014-03-10 | $124.83M 10-K · filed 2014-03-10 | ||||
| 2011-09-30 | $29.22M 10-Q · filed 2012-11-01 | $60.70M derived: sum of 2 quarters · filed 2012-11-01 | $95.46M 10-Q · filed 2012-11-01 | $125.07M derived: sum of 4 quarters · filed 2013-03-08 | ||||
| 2011-06-30 | $31.48M 10-Q · filed 2012-08-03 | $66.24M 10-Q · filed 2012-08-03 | $95.86M derived: sum of 3 quarters · filed 2013-03-08 | $117.01M derived: sum of 4 quarters · filed 2013-03-08 | ||||
| 2011-03-31 | $34.76M 10-Q · filed 2012-05-04 | $64.37M derived: sum of 2 quarters · filed 2013-03-08 | $85.53M derived: sum of 3 quarters · filed 2013-03-08 | $104.13M derived: sum of 4 quarters · filed 2013-03-08 | ||||
| 2010-12-31 | $29.61M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-08 | $50.77M derived: sum of 2 quarters · filed 2013-03-08 | $69.37M derived: sum of 3 quarters · filed 2013-03-08 | $89.30M 10-K · filed 2013-03-08 | ||||
| 2010-09-30 | $21.16M 10-Q · filed 2011-11-04 | $39.76M derived: sum of 2 quarters · filed 2011-11-04 | $59.68M 10-Q · filed 2011-11-04 | |||||
| 2010-06-30 | $18.60M 10-Q · filed 2011-08-05 | $38.52M 10-Q · filed 2011-08-05 | ||||||
| 2009-12-31 | $74.59M 10-K · filed 2012-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |